clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2023-101-1-26-31clinmed-496Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESАртериальная гипертензия при COVID-19Arterial hypertension in COVID-19https://orcid.org/0000-0002-6665-8601ЗмитрукевичА. С.ZmitrukevichА. S.

Змитрукевич Андрей Станиславович — врач общей практики

119331, Москва

Zmitrukevich Andrey S.

119331, Moscow

andrey1881889@gmail.comhttps://orcid.org/0000-0001-9183-3216МамедоваА. Е.MamedovaA. E.

Мамедова Анастасия Евгеньевна — ассистент кафедры биологической химии

230009, Гродно

Mamedova Anastasia E.

230009, Grodno

ГБУЗ «Городская поликлиника № 11 Департамента здравоохранения города Москвы»РоссияCity Polyclinic No. 11 of the Moscow Department of HealthcareRussian FederationУчреждение образования «Гродненский государственный медицинский университет»БеларусьGrodno State Medical UniversityBelarus20232603202310112631Copyright © Змитрукевич А.С., Мамедова А.Е., 20232023Змитрукевич А.С., Мамедова А.Е.Zmitrukevich А.S., Mamedova A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/496

Актуальность. Вирус SARS-CoV-2 стал причиной пандемии COVID-19. Артериальная гипертензия (АГ) при COVID-19 играет важную роль в прогнозе заболеваемости и смертности. Цель. Краткий отчет о влиянии COVID-19 на АГ. Обсуждение. Заболевание COVID-19 достаточно часто сопровождается изменениями со стороны сердечно-сосудистой системы. АГ является одной из самых распространенных сопутствующих заболеваний. Множество исследований доказывают связь АГ с COVID-19. Основными механизмами увеличения показателей артериального давления могут быть увеличение концентрации ангиотензина II в крови, взаимодействие SARS-CoV-2 с рецепторами АПФ2 мембраны клеток инфицированного, прямое и косвенное воздействие на эндотелий, снижение уровня сосудорасширяющих факторов (оксида азота (NO) и простациклина), психологическое давление пандемией COVID-19. Заключение. Терапевты и врачи общей практики должны знать о рисках развития АГ при ведении пациентов с COVID-19, а также диспансеризации населения.

Background. The SARS-CoV-2 virus caused the COVID-19 pandemic. Arterial hypertension in COVID-19 plays an important role in the prognosis of morbidity and mortality. Objective. A brief report on the effect of COVID-19 on arterial hypertension. Discussion. COVID-19 is often accompanied by changes in the cardiovascular system. Arterial hypertension is one of the most common comorbid conditions. A lot of studies have proved the connection of hypertension with COVID-19. The main mechanisms for increasing blood pressure indicators may be: an increase in the concentration of angiotensin II in the blood, the interaction of SARS-CoV-2 with the APF2 receptors of the infected cell membrane, direct and indirect effects on the endothelium, a decrease in the level of vasodilating factors (nitric oxide (NO) and prostacyclin), psychological pressure by the COVID-19 pandemic. Conclusions. Physicians and general practitioners should be aware of hypertension in the management of patients with COVID-19, and the prophylactic medical examination of the population.

артериальная гипертензиягипокалиемияренин-ангиотензинCOVID-19SARS-CoV-2hypertensionhypokalemiarenin-angiotensinCOVID-19SARS-CoV-2ReferencesJi W., Wang W., Zhao X. et al. Cross-species transmission of the newly identifi ed coronavirus 2019-nCoV. Journal of medical virology. 2020;92(4):433–440. DOI: 10.1002/jmv.25682Ji W., Wang W., Zhao X. et al. Cross-species transmission of the newly identifi ed coronavirus 2019-nCoV. Journal of medical virology. 2020;92(4):433–440. DOI: 10.1002/jmv.25682Zmitrukevich A.S. Cardiovascular Changes in COVID19. Acta Scientifi c Medical Sciences. 2022;6(2):32–39. DOI: 10.31080/ASMS.2022.S02.0007Zmitrukevich A.S. Cardiovascular Changes in COVID19. Acta Scientifi c Medical Sciences. 2022;6(2):32–39. DOI: 10.31080/ASMS.2022.S02.0007Rodriguez-Iturbe B., Pons H., Johnson R.J. Role of the immune system in hypertension. Physiological reviews. 2017;97(3):1127–1164. DOI: 10.1152/physrev.00031.2016Rodriguez-Iturbe B., Pons H., Johnson R.J. Role of the immune system in hypertension. Physiological reviews. 2017;97(3):1127–1164. DOI: 10.1152/physrev.00031.2016Bepouka B., Situakibanza H., Sangare M. et al. Mortality associated with COVID-19 and hypertension in sub‐Saharan Africa. A systematic review and meta‐analysis. Journal of Clinical Hypertension. 2022;24(2):99–105. DOI: 10.1111/jch.14417Bepouka B., Situakibanza H., Sangare M. et al. Mortality associated with COVID-19 and hypertension in sub‐Saharan Africa. A systematic review and meta‐analysis. Journal of Clinical Hypertension. 2022;24(2):99–105. DOI: 10.1111/jch.14417Yoshida Y., Gillet S.A., Brown M.I. et al. Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans. Biology of sex Diff erences. 2021;12(1):1–1. DOI: 10.1186/s13293-021-00359-2Yoshida Y., Gillet S.A., Brown M.I. et al. Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans. Biology of sex Diff erences. 2021;12(1):1–1. DOI: 10.1186/s13293-021-00359-2Richardson S., Hirsch J.S., Narasimhan M. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. DOI: 10.1001/jama.2020.6775Richardson S., Hirsch J.S., Narasimhan M. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. DOI: 10.1001/jama.2020.6775Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. DOI: 10.1038/s41586-020-2521-4Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. DOI: 10.1038/s41586-020-2521-4Luan J., Lu Y., Jin X., Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARSCoV-2 infection. Biochemical and biophysical research communications. 2020;526(1):165–169. DOI: 10.1016/j.bbrc.2020.03.047Luan J., Lu Y., Jin X., Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARSCoV-2 infection. Biochemical and biophysical research communications. 2020;526(1):165–169. DOI: 10.1016/j.bbrc.2020.03.047Chen J., Jiang Q., Xia X. et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging cell. 2020;19(7):e13168. DOI: 10.1111/acel.13168Chen J., Jiang Q., Xia X. et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging cell. 2020;19(7):e13168. DOI: 10.1111/acel.13168Wei C., Wan L., Yan Q. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nature metabolism. 2020;2(12):1391– 1400. DOI: 10.1038/s42255-020-00324-0Wei C., Wan L., Yan Q. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nature metabolism. 2020;2(12):1391– 1400. DOI: 10.1038/s42255-020-00324-0Shen W.J., Asthana S., Kraemer F.B., Azhar S. Thematic review series: lipid transfer proteins scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function. Journal of Lipid Research. 2018;59(7):1114–1131. DOI: 10.1194/jlr.R083121Shen W.J., Asthana S., Kraemer F.B., Azhar S. Thematic review series: lipid transfer proteins scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function. Journal of Lipid Research. 2018;59(7):1114–1131. DOI: 10.1194/jlr.R083121Shen W.J, Azhar S., Kraemer F.B. SR-B1: a unique multifunctional receptor for cholesterol infl ux and effl ux. Annual review of physiology. 2018;80:95. DOI: 10.1146/annurev-physiol-021317-12155.0Shen W.J, Azhar S., Kraemer F.B. SR-B1: a unique multifunctional receptor for cholesterol infl ux and effl ux. Annual review of physiology. 2018;80:95. DOI: 10.1146/annurev-physiol-021317-12155.0Ibrahim M.M., Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611–619. DOI: 10.1016/S0140-6736(12)60861-7Ibrahim M.M., Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611–619. DOI: 10.1016/S0140-6736(12)60861-7Danilczyk U., Penninger J.M. Angiotensin-converting enzyme II in the heart and the kidney. Circulation research. 2006;98(4):463–471. DOI: 10.1161/01.RES.0000205761.22353.5fDanilczyk U., Penninger J.M. Angiotensin-converting enzyme II in the heart and the kidney. Circulation research. 2006;98(4):463–471. DOI: 10.1161/01.RES.0000205761.22353.5fTipnis S.R., Hooper N.M., Hyde R. et al. A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Che mistry. 2000;275(43):33238–33243. DOI: 10.1074/jbc.M002615200Tipnis S.R., Hooper N.M., Hyde R. et al. A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Che mistry. 2000;275(43):33238–33243. DOI: 10.1074/jbc.M002615200Patel S., Rauf A., Khan H., Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomedicine & Pharmacotherapy. 2017;94:317–325. DOI: 10.1016/j.biopha.2017.07.091Patel S., Rauf A., Khan H., Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomedicine & Pharmacotherapy. 2017;94:317–325. DOI: 10.1016/j.biopha.2017.07.091Литвинов А.С., Савин А.В., Кухтина А.А. Долгосрочные перспективы внелегочного персистирования коронавируса SARS-CoV-2. Медицина. 2020;8(1):51–73.Litvinov A.S., Savin A.V., Kuhtina A.A. Long-term prospects of extrapulmonary persistence of SARS-CoV-2 coronavirus. Medicine. 2020;8(1):51–73. (In Russian). DOI: 10.29234/2308-9113-2020-8-1-51-73Castoldi G., Carletti R., Ippolito S. et al. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Infl ammatory Cell Infi ltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension. International Journal of Molecular Sciences. 2021;22(24):13678. DOI: 10.3390/ijms222413678Castoldi G., Carletti R., Ippolito S. et al. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Infl ammatory Cell Infi ltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension. International Journal of Molecular Sciences. 2021;22(24):13678. DOI: 10.3390/ijms222413678Taylor P.C., Adams A.C., Huff ord M.M. et al. Neutralizing monoclonal antibodies for treatment of COVID-19. Nature Reviews Immunology. 2021;21(6):382–393. DOI: 10.1038/s41577-021-00542-xTaylor P.C., Adams A.C., Huff ord M.M. et al. Neutralizing monoclonal antibodies for treatment of COVID-19. Nature Reviews Immunology. 2021;21(6):382–393. DOI: 10.1038/s41577-021-00542-xChappell MC, Allred AJ, Ferrario CM. Pathways of angiotensin‐(1– 7) metabolism in the kidney. Nephrology Dialysis Transplantation. 2001;16(1):22–26. DOI: 10.1093/ndt/16.suppl_1.22.Chappell MC, Allred AJ, Ferrario CM. Pathways of angiotensin‐(1– 7) metabolism in the kidney. Nephrology Dialysis Transplantation. 2001;16(1):22–26. DOI: 10.1093/ndt/16.suppl_1.22.Ren L., Yu S., Xu W. et al. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. Journal of Сardiology. 2021;77(5):482–491. DOI: 10.1016/j.jjcc.2020.10.015Ren L., Yu S., Xu W. et al. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. Journal of Сardiology. 2021;77(5):482–491. DOI: 10.1016/j.jjcc.2020.10.015Zhang P., Zhu L., Cai J. et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Кesearch. 2020;126(12):1671– 1681. DOI: 10.1161/CIRCRESAHA.120.317134Zhang P., Zhu L., Cai J. et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Кesearch. 2020;126(12):1671– 1681. DOI: 10.1161/CIRCRESAHA.120.317134Alfaleh M.A., Zawawi A., Al-Amri S.S., Hashem A.M. David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors. MAbs. 2022;14(1):2057832. DOI: 10.1080/19420862.2022.2057832Alfaleh M.A., Zawawi A., Al-Amri S.S., Hashem A.M. David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors. MAbs. 2022;14(1):2057832. DOI: 10.1080/19420862.2022.2057832Imai Y., Kuba K., Rao S. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112– 116. DOI: 10.1038/nature03712Imai Y., Kuba K., Rao S. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112– 116. DOI: 10.1038/nature03712Liu Y., Yang Y., Zhang C. et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China Life Sciences. 2020;63(3):364–374. DOI: 10.1007/s11427-020-1643-8Liu Y., Yang Y., Zhang C. et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China Life Sciences. 2020;63(3):364–374. DOI: 10.1007/s11427-020-1643-8Zoufaly A., Poglitsch M., Aberle J.H. et al. Human recombinant soluble ACE2 in severe COVID-19. The Lancet Respiratory Medicine. 2020;8(11):1154–1158. DOI: 10.1016/S2213-2600(20)30418-5Zoufaly A., Poglitsch M., Aberle J.H. et al. Human recombinant soluble ACE2 in severe COVID-19. The Lancet Respiratory Medicine. 2020;8(11):1154–1158. DOI: 10.1016/S2213-2600(20)30418-5Patel V.B., Parajuli N., Oudit G.Y. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clinical science. 2014;126(7):471–482. DOI: 10.1042/CS20130344Patel V.B., Parajuli N., Oudit G.Y. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clinical science. 2014;126(7):471–482. DOI: 10.1042/CS20130344Berger R.C., Vassallo P.F., Crajoinas R.D. et al. Renal eff ects and underlying molecular mechanisms of long-term salt content diets in spontaneously hypertensive rats. PLoS One. 2015;10(10):e0141288. DOI: 10.1371/journal.pone.0141288Berger R.C., Vassallo P.F., Crajoinas R.D. et al. Renal eff ects and underlying molecular mechanisms of long-term salt content diets in spontaneously hypertensive rats. PLoS One. 2015;10(10):e0141288. DOI: 10.1371/journal.pone.0141288Varga Z., Flammer A.J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417– 1418. DOI: 10.1016/S0140-6736(20)30937-5Varga Z., Flammer A.J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417– 1418. DOI: 10.1016/S0140-6736(20)30937-5Kang S., Tanaka T., Inoue H. et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proceedings of the National Academy of Sciences. 2020;117(36):22351–22356. DOI: 10.1073/pnas.2010229117Kang S., Tanaka T., Inoue H. et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proceedings of the National Academy of Sciences. 2020;117(36):22351–22356. DOI: 10.1073/pnas.2010229117Chang J.C. COVID-19 Sepsis: pathogenesis and endothelial molecular mechanisms based on “two-path unifying theory” of hemostasis and endotheliopathy-associated vascular microthrombotic disease, and proposed therapeutic approach with antimicrothrombotic therapy. Vascular Health and Risk Management. 2021;17:273–298. DOI: 10.2147/VHRM.S299357Chang J.C. COVID-19 Sepsis: pathogenesis and endothelial molecular mechanisms based on “two-path unifying theory” of hemostasis and endotheliopathy-associated vascular microthrombotic disease, and proposed therapeutic approach with antimicrothrombotic therapy. Vascular Health and Risk Management. 2021;17:273–298. DOI: 10.2147/VHRM.S299357Cooke J.P., Connor J.H., Jain A. Acute and chronic cardiovascular manifestations of COVID-19: role for endotheliopathy. Methodist DeBakey Сardiovascular Journal. 2021;17(5):53–62. DOI: 10.14797/mdcvj.1044Cooke J.P., Connor J.H., Jain A. Acute and chronic cardiovascular manifestations of COVID-19: role for endotheliopathy. Methodist DeBakey Сardiovascular Journal. 2021;17(5):53–62. DOI: 10.14797/mdcvj.1044Chang J.C. Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis. Clinical and Applied Thrombosis/Hemostasis. 2019;25:1076029619887437. DOI: 10.1177/1076029619887437Chang J.C. Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis. Clinical and Applied Thrombosis/Hemostasis. 2019;25:1076029619887437. DOI: 10.1177/1076029619887437Tofano R.J., Barbalho S.M., Bechara M.D. et al. Hypertension, C reactive protein and metabolic profi le: what is the scenario in patients undergoing arteriography? Journal of clinical and diagnostic research. 2017;11(8):BC19–BC23. DOI: 10.7860/JCDR/2017/26595.10456Tofano R.J., Barbalho S.M., Bechara M.D. et al. Hypertension, C reactive protein and metabolic profi le: what is the scenario in patients undergoing arteriography? Journal of clinical and diagnostic research. 2017;11(8):BC19–BC23. DOI: 10.7860/JCDR/2017/26595.10456Karakoyun I., Colak A., Turken M. et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. International immunopharmacology. 2021;91:107285. DOI: 10.1016/j.intimp.2020.107285Karakoyun I., Colak A., Turken M. et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. International immunopharmacology. 2021;91:107285. DOI: 10.1016/j.intimp.2020.107285Zeng F., Huang Y., Guo Y. et al. Association of infl ammatory markers with the severity of COVID-19: a meta-analysis. International Journal of Infectious Diseases. 2020;96:467–474. DOI: 10.1016/j.ijid.2020.05.055Zeng F., Huang Y., Guo Y. et al. Association of infl ammatory markers with the severity of COVID-19: a meta-analysis. International Journal of Infectious Diseases. 2020;96:467–474. DOI: 10.1016/j.ijid.2020.05.055Roohafza H., Sattari N., Nouri F. et al. Do any kinds of perceived stressors lead to hypertension? A longitudinal cohort study. Hypertension Research. 2022;45(6):1058–1066. DOI: 10.1038/s41440-022-00895-3Roohafza H., Sattari N., Nouri F. et al. Do any kinds of perceived stressors lead to hypertension? A longitudinal cohort study. Hypertension Research. 2022;45(6):1058–1066. DOI: 10.1038/s41440-022-00895-3Burtscher J., Burtscher M., Millet G.P. (Indoor) isolation, stress and physical inactivity: vicious circles accelerated by Covid-19? Scandinavian journal of medicine & science in sports. 2020;30(8):1544– 1545. DOI: 10.1111/sms.13706Burtscher J., Burtscher M., Millet G.P. (Indoor) isolation, stress and physical inactivity: vicious circles accelerated by Covid-19? Scandinavian journal of medicine & science in sports. 2020;30(8):1544– 1545. DOI: 10.1111/sms.13706Kobayashi K., Chin K., Umezawa S. et al. Infl uence of stress induced by the fi rst announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan. Hypertension Research. 2022;45(4):675–685. DOI: 10.1038/s41440-021-00832-wKobayashi K., Chin K., Umezawa S. et al. Infl uence of stress induced by the fi rst announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan. Hypertension Research. 2022;45(4):675–685. DOI: 10.1038/s41440-021-00832-wBozzani A., Arici V., Ticozzelli G. et al. Reduced Vascular Practice and Increased Cardiovascular Mortality for COVID-19–Negative Patients. Journal of Surgical Research. 2022;272:146–152. DOI: 10.1016/j.jss.2021.11.014Bozzani A., Arici V., Ticozzelli G. et al. Reduced Vascular Practice and Increased Cardiovascular Mortality for COVID-19–Negative Patients. Journal of Surgical Research. 2022;272:146–152. DOI: 10.1016/j.jss.2021.11.014Wang X., Gao H., Zhang Z. et al. Eff ect of the COVID-19 pandemic on complications and mortality of patients with cardiac surgery. Journal of Cardiothoracic Surgery. 2021;16(1):1–9. DOI: 10.1186/s13019-021-01744-zWang X., Gao H., Zhang Z. et al. Eff ect of the COVID-19 pandemic on complications and mortality of patients with cardiac surgery. Journal of Cardiothoracic Surgery. 2021;16(1):1–9. DOI: 10.1186/s13019-021-01744-zFanton L., Nahmani I., Epain M. et al. Forensic autopsy-confi rmed COVID-19-induced out-of-hospital cardiac arrest. Annals of Translational Medicine. 2021;9(23):1715. DOI: 10.21037/atm-21-3918Fanton L., Nahmani I., Epain M. et al. Forensic autopsy-confi rmed COVID-19-induced out-of-hospital cardiac arrest. Annals of Translational Medicine. 2021;9(23):1715. DOI: 10.21037/atm-21-3918Nia H.S., Long She L., Kaur H. et al. A predictive study between anxiety and fear of COVID-19 with psychological behavior response: the mediation role of perceived stress. Frontiers in Psychiatry. 2022;13:851212. DOI: 10.3389/fpsyt.2022.851212Nia H.S., Long She L., Kaur H. et al. A predictive study between anxiety and fear of COVID-19 with psychological behavior response: the mediation role of perceived stress. Frontiers in Psychiatry. 2022;13:851212. DOI: 10.3389/fpsyt.2022.851212

The authors declare that there are no conflicts of interest present.